Obesity-drug developer BioAge Labs Inc. gained about 20% after its initial public offering on Thursday, while natural-gas ...

Headlines,BKV made a successful debut on the New York Stock Exchange, achieving a significant market capitalization.,The ...

BKV shares rose by 3.1% on their New York Stock Exchange debut on Thursday. This gives the U.S. Natural Gas Producer a market cap of $1.56 Billion.

(Reuters) -Shares of BKV rose 3.1% in their debut on the New York Stock Exchange on Thursday, giving the U.S. natural gas ...

As the company is focused on developing treatments for autoimmune diseases, it is also developing MAU868, a monoclonal ...

Japanese conglomerate Mitsubishi will acquire a 10% stake in a Sarawak natural gas liquefaction facility run by Malaysian state energy firm Petroliam Nasional for a ten-year period by the end of 2024, ...

Texas-based Barnett Shale driller BKV Inc. priced below the estimated range, while obesity-drug developer BioAge Labs Inc. priced midrange ahead of their first day of trading on Thursday. As the ...

Texas-based Barnett Shale driller prices below the estimated range, while obesity-drug developer BioAge prices midrange ahead ...

NEW YORK (AP) — U.S. stocks are rising toward another record on Thursday as financial markets around the world rally again. The S&P 500 was 0.5% higher in morning trading and on track to set an ...

BKV Corporation ("BKV") today announced the pricing of its initial public offering of 15,000,000 shares of its common stock ...

Natural gas producer BKV Corp said on Wednesday it had raised $270 million in its U.S. initial public offering.